3.03
price up icon18.82%   0.48
pre-market  Pre-mercato:  3.07   0.04   +1.32%
loading
Precedente Chiudi:
$2.55
Aprire:
$2.53
Volume 24 ore:
3.33M
Relative Volume:
1.38
Capitalizzazione di mercato:
$210.01M
Reddito:
$14.79M
Utile/perdita netta:
$-102.44M
Rapporto P/E:
-0.9967
EPS:
-3.04
Flusso di cassa netto:
$-91.73M
1 W Prestazione:
+11.81%
1M Prestazione:
-34.13%
6M Prestazione:
-47.94%
1 anno Prestazione:
-65.17%
Intervallo 1D:
Value
$2.5088
$3.09
Intervallo di 1 settimana:
Value
$2.45
$3.09
Portata 52W:
Value
$2.45
$10.99

Solid Biosciences Inc Stock (SLDB) Company Profile

Name
Nome
Solid Biosciences Inc
Name
Telefono
617-337-4680
Name
Indirizzo
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Name
Dipendente
100
Name
Cinguettio
@SolidBioDMD
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
SLDB's Discussions on Twitter

Confronta SLDB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SLDB
Solid Biosciences Inc
3.03 210.01M 14.79M -102.44M -91.73M -3.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-08 Iniziato Truist Buy
2024-12-13 Iniziato Wedbush Outperform
2024-12-10 Iniziato JMP Securities Mkt Outperform
2024-07-15 Aggiornamento JP Morgan Neutral → Overweight
2024-06-24 Aggiornamento Leerink Partners Market Perform → Outperform
2024-05-31 Ripresa Piper Sandler Overweight
2024-03-28 Iniziato William Blair Outperform
2024-03-15 Iniziato Citigroup Buy
2024-03-14 Aggiornamento Piper Sandler Neutral → Overweight
2023-12-08 Iniziato H.C. Wainwright Buy
2021-07-12 Iniziato Piper Sandler Neutral
2021-05-27 Iniziato Jefferies Buy
2021-03-16 Aggiornamento SVB Leerink Mkt Perform → Outperform
2021-03-09 Iniziato Barclays Overweight
2021-01-08 Aggiornamento Credit Suisse Underperform → Neutral
2020-07-28 Downgrade SVB Leerink Outperform → Mkt Perform
2020-05-07 Downgrade Evercore ISI Outperform → In-line
2019-10-11 Iniziato Evercore ISI Outperform
2019-08-29 Downgrade Citigroup Neutral → Sell
2019-08-19 Aggiornamento SVB Leerink Mkt Perform → Outperform
2019-08-16 Aggiornamento Chardan Capital Markets Neutral → Buy
2019-05-14 Downgrade Credit Suisse Neutral → Underperform
2019-05-14 Downgrade Goldman Neutral → Sell
2019-02-08 Aggiornamento Citigroup Sell → Neutral
2019-02-08 Downgrade SVB Leerink Outperform → Mkt Perform
2018-11-06 Iniziato Citigroup Sell
2018-09-06 Iniziato Credit Suisse Neutral
Mostra tutto

Solid Biosciences Inc Borsa (SLDB) Ultime notizie

pulisher
Apr 19, 2025

Certain Restricted Stock Units of Solid Biosciences Inc. are subject to a Lock-Up Agreement Ending on 20-APR-2025. - marketscreener.com

Apr 19, 2025
pulisher
Apr 19, 2025

Certain Common Stock of Solid Biosciences Inc. are subject to a Lock-Up Agreement Ending on 20-APR-2025. - marketscreener.com

Apr 19, 2025
pulisher
Apr 16, 2025

Solid Biosciences stock hits 52-week low at $2.47 By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 16, 2025

Solid Biosciences stock hits 52-week low at $2.47 - Investing.com Australia

Apr 16, 2025
pulisher
Apr 13, 2025

Can Solid Biosciences Challenge Sarepta in the DMD Market? - MSN

Apr 13, 2025
pulisher
Apr 08, 2025

Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space - Seeking Alpha

Apr 08, 2025
pulisher
Apr 07, 2025

Solid Biosciences stock hits 52-week low at $2.88 - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

Solid Biosciences stock hits 52-week low at $2.88 By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewswire

Apr 07, 2025
pulisher
Apr 07, 2025

Exclusive Access: Solid Biosciences Leadership Team Headlines Two Major Healthcare Conferences - Stock Titan

Apr 07, 2025
pulisher
Apr 01, 2025

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Solid Biosciences reports inducement grants under Nasdaq listing rule - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Solid Biosciences Expands Team with 43,374 RSU Grants in Strategic Hiring Move - Stock Titan

Apr 01, 2025
pulisher
Mar 20, 2025

Sarepta safety update on Elevidys boosts Regenxbio, hurts Solid Bio - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Truist Financial Keeps Their Buy Rating on Solid Biosciences (SLDB) - The Globe and Mail

Mar 20, 2025
pulisher
Mar 19, 2025

Solid Biosciences Inc.'s (NASDAQ:SLDB) market cap dropped US$53m last week; Private equity firms bore the brunt - simplywall.st

Mar 19, 2025
pulisher
Mar 18, 2025

Regenxbio stock up, Solid Bio down post Sarepta update (RGNX) - Seeking Alpha

Mar 18, 2025
pulisher
Mar 14, 2025

Solid Biosciences Inc. (SLDB): Among Top Insider Purchases Last Month - Insider Monkey

Mar 14, 2025
pulisher
Mar 13, 2025

Solid Biosciences director Kahn Clare buys $9,924 in stock - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Solid Biosciences director Kahn Clare buys $9,924 in stock By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Solid Biosciences’ SWOT analysis: gene therapy firm’s stock poised for growth - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Solid Biosciences’ SWOT analysis: gene therapy firm’s stock poised for growth By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Solid Biosciences Inc. (NASDAQ:SLDB) Short Interest Update - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Q1 EPS Forecast for Solid Biosciences Boosted by Analyst - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Top 10 Insider Purchases Last Month - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Solid Biosciences Inc. to Present Phase 1/2 INSPIRE DUCHENNE Trial Data on SGT-003 Gene Therapy for Duchenne Muscular Dystrophy at 2025 MDA Conference - Nasdaq

Mar 12, 2025
pulisher
Mar 12, 2025

Breakthrough DMD Gene Therapy Results: Solid Bio Reveals INSPIRE Trial Data at Major Conference - StockTitan

Mar 12, 2025
pulisher
Mar 11, 2025

Solid Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Solid Biosciences Inc. (NASDAQ:SLDB) Shares Acquired by Rhumbline Advisers - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

HC Wainwright Issues Positive Forecast for Solid Biosciences (NASDAQ:SLDB) Stock Price - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Solid Biosciences shares leap on raised price target to $20 By Investing.com - Investing.com Canada

Mar 10, 2025
pulisher
Mar 10, 2025

Solid Biosciences price target raised to $20 from $16 at H.C. Wainwright - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

FY2026 Earnings Forecast for SLDB Issued By William Blair - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Chardan Capital Reaffirms “Buy” Rating for Solid Biosciences (NASDAQ:SLDB) - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

SLDB Stock Rallies 60% in a Month: Here's What You Should Know - MSN

Mar 07, 2025
pulisher
Mar 07, 2025

Wall Street Analysts Believe Solid Biosciences (SLDB) Could Rally 198.18%: Here's is How to Trade - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Solid Biosciences Inc expected to post a loss of 60 cents a shareEarnings Preview - TradingView

Mar 07, 2025
pulisher
Mar 07, 2025

Solid Biosciences stock target holds at $15 on therapy optimism - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Solid Biosciences: Promising Gene Therapy Advancements and Strategic Pipeline Expansion Justify Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Solid Biosciences: Positive DMD Program Developments and Strong Financial Position Justify Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire

Mar 07, 2025

Solid Biosciences Inc Azioni (SLDB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Capitalizzazione:     |  Volume (24 ore):